OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Clinical trial NCT06420297 · TERMINATED
Trial details
- NCT number
- NCT06420297
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2025-12-19
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.